Annual Total Assets
$4.21 M
-$4.24 M-50.21%
December 31, 2023
Summary
- As of February 8, 2025, BCLI annual total assets is $4.21 million, with the most recent change of -$4.24 million (-50.21%) on December 31, 2023.
- During the last 3 years, BCLI annual total assets has fallen by -$47.05 million (-91.79%).
- BCLI annual total assets is now -91.79% below its all-time high of $51.26 million, reached on December 31, 2020.
Performance
BCLI Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$2.02 M
-$3.66 M-64.37%
September 30, 2024
Summary
- As of February 8, 2025, BCLI quarterly total assets is $2.02 million, with the most recent change of -$3.66 million (-64.37%) on September 30, 2024.
- Over the past year, BCLI quarterly total assets has dropped by -$3.66 million (-64.37%).
- BCLI quarterly total assets is now -96.05% below its all-time high of $51.26 million, reached on December 31, 2020.
Performance
BCLI Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
BCLI Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -50.2% | -64.4% |
| 3 y3 years | -91.8% | -64.4% |
| 5 y5 years | -62.5% | -64.4% |
BCLI Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -85.6% | at low | -93.1% | at low |
| 5 y | 5-year | -91.8% | at low | -96.0% | at low |
| alltime | all time | -91.8% | >+9999.0% | -96.0% | >+9999.0% |
Brainstorm Cell Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.02 M(-64.4%) |
| Jun 2024 | - | $5.68 M(+69.7%) |
| Mar 2024 | - | $3.35 M(-20.4%) |
| Dec 2023 | $4.21 M(-50.2%) | $4.21 M(-25.9%) |
| Sep 2023 | - | $5.68 M(-1.1%) |
| Jun 2023 | - | $5.75 M(-27.0%) |
| Mar 2023 | - | $7.87 M(-6.9%) |
| Dec 2022 | $8.45 M(-71.1%) | $8.45 M(-36.2%) |
| Sep 2022 | - | $13.25 M(-30.1%) |
| Jun 2022 | - | $18.96 M(-26.5%) |
| Mar 2022 | - | $25.79 M(-11.9%) |
| Dec 2021 | $29.28 M(-42.9%) | $29.28 M(-15.2%) |
| Sep 2021 | - | $34.54 M(-18.2%) |
| Jun 2021 | - | $42.23 M(-13.0%) |
| Mar 2021 | - | $48.57 M(-5.2%) |
| Dec 2020 | $51.26 M(+684.5%) | $51.26 M(+56.8%) |
| Sep 2020 | - | $32.69 M(+70.1%) |
| Jun 2020 | - | $19.22 M(+6.4%) |
| Mar 2020 | - | $18.07 M(+176.6%) |
| Dec 2019 | $6.53 M(-41.8%) | $6.53 M(-16.3%) |
| Sep 2019 | - | $7.81 M(-11.9%) |
| Jun 2019 | - | $8.86 M(-25.2%) |
| Mar 2019 | - | $11.85 M(+5.5%) |
| Dec 2018 | $11.23 M(-1.7%) | $11.23 M(-18.5%) |
| Sep 2018 | - | $13.77 M(-34.5%) |
| Jun 2018 | - | $21.02 M(+123.3%) |
| Mar 2018 | - | $9.41 M(-17.6%) |
| Dec 2017 | $11.42 M(+6.1%) | $11.42 M(+0.8%) |
| Sep 2017 | - | $11.34 M(+41.7%) |
| Jun 2017 | - | $8.00 M(-11.4%) |
| Mar 2017 | - | $9.03 M(-16.1%) |
| Dec 2016 | $10.77 M(-37.0%) | $10.77 M(-8.2%) |
| Sep 2016 | - | $11.72 M(-10.9%) |
| Jun 2016 | - | $13.15 M(-4.8%) |
| Mar 2016 | - | $13.81 M(-19.1%) |
| Dec 2015 | $17.08 M(+72.3%) | $17.08 M(-7.0%) |
| Sep 2015 | - | $18.36 M(-9.8%) |
| Jun 2015 | - | $20.36 M(-9.0%) |
| Mar 2015 | - | $22.39 M(+125.9%) |
| Dec 2014 | $9.91 M(+109.7%) | $9.91 M(-13.1%) |
| Sep 2014 | - | $11.40 M(-9.0%) |
| Jun 2014 | - | $12.52 M(+198.7%) |
| Mar 2014 | - | $4.19 M(-11.3%) |
| Dec 2013 | $4.73 M | $4.73 M(-23.9%) |
| Sep 2013 | - | $6.21 M(+63.7%) |
| Jun 2013 | - | $3.79 M(-20.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $4.75 M(-7.5%) |
| Dec 2012 | $5.14 M(+87.2%) | $5.14 M(-10.2%) |
| Sep 2012 | - | $5.72 M(+209.2%) |
| Jun 2012 | - | $1.85 M(-17.7%) |
| Mar 2012 | - | $2.25 M(-18.0%) |
| Dec 2011 | $2.74 M(+152.0%) | $2.74 M(-15.4%) |
| Sep 2011 | - | $3.25 M(-10.3%) |
| Jun 2011 | - | $3.62 M(-17.9%) |
| Mar 2011 | - | $4.40 M(+304.3%) |
| Dec 2010 | $1.09 M(+43.9%) | $1.09 M(-21.3%) |
| Sep 2010 | - | $1.38 M(-6.2%) |
| Jun 2010 | - | $1.48 M(-26.0%) |
| Mar 2010 | - | $1.99 M(+163.1%) |
| Dec 2009 | $757.00 K(-13.5%) | $757.00 K(-6.0%) |
| Sep 2009 | - | $805.00 K(-2.4%) |
| Jun 2009 | - | $825.00 K(-1.9%) |
| Mar 2009 | - | $841.00 K(-3.9%) |
| Dec 2008 | $875.00 K(-19.2%) | $875.00 K(-16.8%) |
| Sep 2008 | - | $1.05 M(-6.3%) |
| Jun 2008 | - | $1.12 M(+3.6%) |
| Mar 2008 | - | $1.08 M(+0.1%) |
| Dec 2007 | $1.08 M(+49.8%) | $1.08 M(+9.8%) |
| Sep 2007 | - | $986.00 K(+45.4%) |
| Jun 2007 | - | $678.00 K(-2.5%) |
| Mar 2007 | - | $695.20 K(-4.2%) |
| Dec 2006 | $723.00 K(-15.9%) | - |
| Sep 2006 | - | $725.50 K(-25.8%) |
| Jun 2006 | - | $978.40 K(+13.8%) |
| Mar 2006 | - | $859.80 K(+46.0%) |
| Mar 2006 | $859.80 K(-2.2%) | - |
| Dec 2005 | - | $589.10 K(-28.8%) |
| Sep 2005 | - | $827.90 K(-4.9%) |
| Jun 2005 | - | $870.40 K(-1.0%) |
| Mar 2005 | $879.40 K(+5328.4%) | $879.40 K(+185.5%) |
| Dec 2004 | - | $308.00 K(+464.1%) |
| Sep 2004 | - | $54.60 K(-19.7%) |
| Jun 2004 | - | $68.00 K(+319.8%) |
| Mar 2004 | $16.20 K(-64.4%) | $16.20 K(-58.5%) |
| Dec 2003 | - | $39.00 K(-3.2%) |
| Sep 2003 | - | $40.30 K(+2.3%) |
| Jun 2003 | - | $39.40 K(-13.4%) |
| Mar 2003 | $45.50 K(-28.6%) | $45.50 K(-20.5%) |
| Dec 2002 | - | $57.20 K(-32.8%) |
| Sep 2002 | - | $85.10 K(-4.6%) |
| Jun 2002 | - | $89.20 K |
| Mar 2002 | $63.70 K | - |
FAQ
- What is Brainstorm Cell Therapeutics annual total assets?
- What is the all time high annual total assets for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics annual total assets year-on-year change?
- What is Brainstorm Cell Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Brainstorm Cell Therapeutics?
- What is Brainstorm Cell Therapeutics quarterly total assets year-on-year change?
What is Brainstorm Cell Therapeutics annual total assets?
The current annual total assets of BCLI is $4.21 M
What is the all time high annual total assets for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high annual total assets is $51.26 M
What is Brainstorm Cell Therapeutics annual total assets year-on-year change?
Over the past year, BCLI annual total assets has changed by -$4.24 M (-50.21%)
What is Brainstorm Cell Therapeutics quarterly total assets?
The current quarterly total assets of BCLI is $2.02 M
What is the all time high quarterly total assets for Brainstorm Cell Therapeutics?
Brainstorm Cell Therapeutics all-time high quarterly total assets is $51.26 M
What is Brainstorm Cell Therapeutics quarterly total assets year-on-year change?
Over the past year, BCLI quarterly total assets has changed by -$3.66 M (-64.37%)